X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/marius-pharmaceuticals-announces-final-published-phase-3-data-from-mrs-tu-2019ext-studying-the-safety-and-efficacy-of-fda-approved-kyzatrex-testosterone-undecanoate-cii-capsules-302114685.html
https://www.globenewswire.com//news-release/2023/09/19/2745752/0/en/Marius-Pharmaceuticals-Expands-Access-of-KYZATREX-testosterone-undecanoate-to-Department-of-Veterans-Affairs-VA-Pledging-Support-for-Proper-Hormonal-Balance-Among-Military-Personne.html
https://www.prnewswire.com/news-releases/tolmar-announces-acquisition-of-jatenzo-testosterone-undecanoate-for-the-treatment-of-hypogonadism-to-expand-its-market-leading-urology-portfolio-301662003.html
https://www.globenewswire.com/news-release/2022/09/06/2509977/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Plan-for-Near-Term-Sale-of-JATENZO-Using-Structured-Process-Through-Chapter-11-of-the-U-S-Bankruptcy-Code.html
https://www.fiercepharma.com/pharma/clarus-future-looks-hazy-its-pandemic-era-launch-jatenzo-falters-triggering-layoffs-and-rd
https://www.globenewswire.com/news-release/2022/08/02/2490407/0/en/Marius-Pharmaceuticals-Receives-FDA-Approval-of-KYZATREX-an-Oral-Testosterone-Replacement-Therapy.html
https://www.globenewswire.com/news-release/2022/06/09/2459788/19989/en/Clarus-Therapeutics-to-Present-New-Data-for-JATENZO-testosterone-undecanoate-at-ENDO-2022-the-Endocrine-Society-s-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/04/28/2431549/19989/en/Clarus-Therapeutics-Announces-Notice-of-Allowance-for-Patent-Claims-Covering-JATENZO-testosterone-undecanoate.html
https://www.globenewswire.com/news-release/2022/04/19/2424580/19989/en/Clarus-Therapeutics-to-Present-New-Data-for-JATENZO-testosterone-undecanoate-at-the-Androgen-Society-4th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/02/24/2391365/19989/en/Clarus-Announces-Strategic-Partnerships-for-JATENZO-testosterone-undecanoate-with-Vault-Health-and-AssistRx-Leaders-in-Providing-Healthcare-Services-to-Patients.html
https://www.globenewswire.com/news-release/2022/02/03/2378482/35385/en/Antares-Pharma-Announces-FDA-Acceptance-of-NDA-Resubmission-for-TLANDO.html
https://www.prnewswire.com/news-releases/lipocine-announces-its-partner-received-fda-acceptance-of-nda-resubmission-for-tlando-301474456.html
https://www.prnewswire.com/news-releases/lipocine-announces-peer-reviewed-publication-of-phase-3-study-results-for-tlando-301469292.html
https://www.prnewswire.com/news-releases/endo-announces-publication-of-new-aveed-testosterone-undecanoate-data-in-peer-reviewed-journal-of-clinical-pharmacology-data-evaluates-dosing-flexibility-in-men-with-hypogonadism-301460039.html
https://www.globenewswire.com/news-release/2021/10/26/2320792/19989/en/Clarus-Therapeutics-Announces-Two-Notices-of-Allowance-for-Patent-Claims-Covering-JATENZO-testosterone-undecanoate.html
https://www.globenewswire.com/news-release/2019/12/11/1959482/0/en/Clarus-Therapeutics-Expands-Executive-Team-in-Preparation-for-Landmark-Launch-of-JATENZO-testosterone-undecanoate-Capsules-CIII.html
https://www.prnewswire.com/news-releases/lipocine-announces-trial-date-in-lipocines-infringement-lawsuit-against-clarus-therapeutics-and-will-seek-a-permanent-injunction-300907209.html
https://www.globenewswire.com/news-release/2019/08/19/1903506/0/en/Clarus-Therapeutics-Announces-FDA-Award-of-3-Year-Market-Exclusivity-for-Jatenzo.html
https://www.fiercebiotech.com/biotech/male-birth-control-pill-shows-promise-but-needs-further-study
http://www.pharmamanufacturing.com/industrynews/2017/endo-bayer-win-patent-suit-for-testosterone-drug/
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207583
Market Place
Share 
